<DOC>
	<DOCNO>NCT02991235</DOCNO>
	<brief_summary>A 6-month randomized , double-blind placebo-controlled , follow 6-month open label extension study .</brief_summary>
	<brief_title>Efficacy Safety PRJ212 Improve Memory Patients With Mild Severity Alzheimer 's Disease</brief_title>
	<detailed_description>Men woman 60 85 year old diagnosis mild severity Alzheimer 's disease , accord diagnostic criterion establish National Institute Neurological Communicative Disorders Stroke Alzheimer 's Disease Related Disorders Associations ( NINCDS-ADRDA ) .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Patients age 60 85 year . Patients diagnosis probable possible Alzheimer 's disease accord NINCDSADRDA . Patients mild Alzheimer 's disease accord MMSE . Patients ability ingest oral medication . Patients able undergo MRI . Pregnant breastfeed woman plan pregnancy study . Patients caregiver unwilling unable perform cognitive testing . Patients take part interventional clinical trial . Patients risk noncompliance study procedure . Patients clinical significant laboratory abnormality . Patients treat concomitant treatment food supplement could interfere evaluation criterion .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>